Keppra and Gleevec drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Keppra (levetiracetam) and Gleevec (imatinib mesylate). Common drug interactions include fatigue among females and asthenia among males.

The phase IV clinical study analyzes what interactions people have when they take Keppra and Gleevec. It is created by eHealthMe based on reports of 79 people who take the same drugs from the FDA, and is updated regularly.

What is Keppra?

Keppra has active ingredients of levetiracetam. It is often used in epilepsy. eHealthMe is studying from 73,504 Keppra users. Check the latest studies of Keppra.

What is Gleevec?

Gleevec has active ingredients of imatinib mesylate. It is often used in chronic myelogenous leukemia (cml). eHealthMe is studying from 35,415 Gleevec users. Check the latest studies of Gleevec.



On Jul, 11, 2026

79 people who take Keppra and Gleevec together, and have interactions are studied.

Keppra and Gleevec drug interactions.

What are the common drug interactions of Keppra and Gleevec, by gender? *:

female:

  1. Fatigue (feeling of tiredness)
  2. Rash
  3. Death
  4. Malignant neoplasm progression (cancer tumour came back)
  5. Muscle spasms (muscle contraction)
  6. Anxiety
  7. Depression
  8. Diarrhoea
  9. Myalgia (muscle pain)
  10. Pain

male:

  1. Asthenia (weakness)
  2. Death
  3. Alanine aminotransferase increased
  4. Aspartate aminotransferase increased
  5. Brain oedema (excess accumulation of fluid in the intracellular or extracellular spaces of the brain)
  6. Dyspnoea exertional (breathlessness or shortness of breath)
  7. Fatigue (feeling of tiredness)
  8. Grand mal convulsion (a type of generalized seizure that affects the entire brain)
  9. Heart rate increased
  10. Hemiparesis (weakness on one side of the body)

What are the common drug interactions of Keppra and Gleevec, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Acute lymphocytic leukaemia recurrent (cancer in which the bone marrow makes too many lymphocytes-recurrent)
  2. Adrenal insufficiency (a condition in which the adrenal glands do not produce adequate amounts of steroids)
  3. Anaemia (lack of blood)
  4. Bacterascites (bacterial infection of ascetic fluid)
  5. Blood pressure decreased
  6. Cardiac murmur (an heart sound in valve abnormality)
  7. Depression
  8. Dyspnoea (difficult or laboured respiration)
  9. Eating disorder
  10. Fatigue (feeling of tiredness)

20-29:

  1. Abdominal hernia
  2. Alopecia (absence of hair from areas of the body)
  3. Coma (state of unconsciousness lasting more than six hours)
  4. Death
  5. Hernia (hernia happens when part of an internal organ or tissue bulges through a weak area of muscle)
  6. Iodine allergy
  7. Renal failure (kidney dysfunction)
  8. Vomiting

30-39:

  1. Headache (pain in head)
  2. Heart rate increased
  3. Hyperhidrosis (abnormally increased sweating)
  4. Muscle contractions involuntary (uncontrolled muscle contraction)
  5. Muscle spasms (muscle contraction)
  6. Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
  7. Brain oedema (excess accumulation of fluid in the intracellular or extracellular spaces of the brain)
  8. Disturbance in attention
  9. Drug withdrawal syndrome (interfere with normal social, occupational, or other functioning. are not due to another medical condition, drug use, or discontinuation)
  10. Dyspnoea exertional (breathlessness or shortness of breath)

40-49:

  1. Brain oedema (excess accumulation of fluid in the intracellular or extracellular spaces of the brain)
  2. Cognitive disorder (mental health disorders affects learning, memory, perception, and problem solving)
  3. Cough
  4. Headache (pain in head)
  5. Hydrocephalus (water on the brain)
  6. Metastases to central nervous system (cancer spreads to central nervous system)
  7. Metastases to lung (cancer spreads to lung)
  8. Nausea (feeling of having an urge to vomit)
  9. Pulmonary oedema (fluid accumulation in the lungs)
  10. Alanine aminotransferase increased

50-59:

  1. Blood albumin decreased
  2. Blood bilirubin increased
  3. Blood calcium decreased
  4. Blood phosphorus decreased
  5. Cirrhosis alcoholic (chronic disease of the liver marked by degeneration of cells, inflammation, and fibrous thickening of tissue caused by alcoholism)
  6. Encephalopathy (functioning of the brain is affected by some agent or condition)
  7. Glomerular filtration rate decreased
  8. Haematocrit decreased
  9. Haemoglobin decreased
  10. Haemorrhage intracranial (bleeding within the skull)

60+:

  1. Asthenia (weakness)
  2. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
  3. Peripheral motor neuropathy (muscles in the body become progressively weaker over months to years)
  4. Brain neoplasm (tumour of brain)
  5. Death
  6. Fatigue (feeling of tiredness)
  7. Mental status changes (general changes in brain function, such as confusion, amnesia (memory loss), loss of alertness, loss of orientation)
  8. Pleural effusion (water on the lungs)
  9. Rash
  10. Urticaria (rash of round, red welts on the skin that itch intensely)

What are the existing conditions these people have? *

  1. Glioblastoma Multiforme (most common and deadliest of malignant primary brain tumours in adults): 15 people, 18.99%
  2. Chronic Myeloid Leukaemia (long lasting type of cancer that starts in the blood-forming cells of the bone marrow and invades the blood): 11 people, 13.92%
  3. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body): 8 people, 10.13%
  4. Gastrointestinal Stromal Tumor: 6 people, 7.59%
  5. Glioblastoma (most common and most aggressive malignant primary brain tumour in humans): 5 people, 6.33%
  6. Astrocytoma (tumour of the brain that originate in a particular kind of glial-cells): 5 people, 6.33%
  7. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 4 people, 5.06%
  8. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 4 people, 5.06%

* Approximation only. Some reports may have incomplete information.

Do you take Keppra and Gleevec?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Keppra and Gleevec:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Keppra:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Gleevec:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Keppra and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Gleevec and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on levetiracetam and imatinib mesylate (the active ingredients of Keppra and Gleevec, respectively), and Keppra and Gleevec (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: